- The Institute
- Travel & Vaccines
“Selection Linked Integration (SLI) allowed us for the first time to localize Kelch13, the protein associated with resistance to artemisinin, the most important malaria drug”, highlights Dr. Tobias Spielmann…
BNITM und the University of Hamburg seek to analyze immune competence as a putative driving force in the preservation of primate diversity. They will look at Maki species in Madagascar and ...
Application deadline: March 27, 2017.
Photo: ©Jacques Rakotondranary
In cooperation with the Tehran University of Medical Sciences (TUMS), BNITM together with the Hamburg University of Applied Sciences (HAW) and the University Medical Center Hamburg-Eppendorf (UKE) launched a three-week postgraduate course …
Recommendation scheme: available in English
Further information: available in German
“The affected countries will have a major problem if we do not manage to control salmonella bloodstream infections with new antibiotics such as ciprofloxacin,” cautions Prof Jürgen May …
Scientists of the Heinrich Pette Institute (HPI) and the BNITM evaluated for the first time Ebola virus disease (EVD) patients at the time of admission at the Ebola Treatment Center in Guinea, and longitudinally until discharge or death. The results have been published in the renowned journal "Nature" …
Tel.: +49 40 42818-0
(Switchboard of the Institute)
Tel.: +49 40 312851
Fax: +49 40 42818-400